| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children
|
Anh, Dang Duc
|
|
2012
|
30 |
S1 |
p. A114-A121
nvt p.
|
article
|
| 2 |
Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine
|
Breiman, Robert F.
|
|
2012
|
30 |
S1 |
p. A24-A29
nvt p.
|
article
|
| 3 |
A systematic review of rotavirus strain diversity in India, Bangladesh, and Pakistan
|
Miles, Melody G.
|
|
2012
|
30 |
S1 |
p. A131-A139
nvt p.
|
article
|
| 4 |
Characterisation of a G9P[8] rotavirus strain identified during a gastroenteritis outbreak in Alice Springs, Australia post Rotarix™ vaccine introduction
|
Donato, C.M.
|
|
2012
|
30 |
S1 |
p. A152-A158
nvt p.
|
article
|
| 5 |
Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and Asia
|
Lewis, Kristen D.C.
|
|
2012
|
30 |
S1 |
p. A159-A166
nvt p.
|
article
|
| 6 |
Distributional impact of rotavirus vaccination in 25 GAVI countries: Estimating disparities in benefits and cost-effectiveness
|
Rheingans, Richard
|
|
2012
|
30 |
S1 |
p. A15-A23
nvt p.
|
article
|
| 7 |
Editorial Board/Aims and Scope
|
|
|
2012
|
30 |
S1 |
p. CO2-
1 p.
|
article
|
| 8 |
Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: A randomized, double-blind, placebo-controlled trial
|
Madhi, S.A.
|
|
2012
|
30 |
S1 |
p. A44-A51
nvt p.
|
article
|
| 9 |
Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo controlled trial
|
Cunliffe, Nigel A.
|
|
2012
|
30 |
S1 |
p. A36-A43
nvt p.
|
article
|
| 10 |
Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya
|
Feikin, Daniel R.
|
|
2012
|
30 |
S1 |
p. A52-A60
nvt p.
|
article
|
| 11 |
Efficacy of the oral pentavalent rotavirus vaccine in Mali
|
Sow, Samba O.
|
|
2012
|
30 |
S1 |
p. A71-A78
nvt p.
|
article
|
| 12 |
Five-year cohort study on the burden of hospitalisation for acute diarrhoeal disease in African HIV-infected and HIV-uninfected children: Potential benefits of rotavirus vaccine
|
Groome, Michelle J.
|
|
2012
|
30 |
S1 |
p. A173-A178
nvt p.
|
article
|
| 13 |
Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam
|
Shin, Sunheang
|
|
2012
|
30 |
S1 |
p. A106-A113
nvt p.
|
article
|
| 14 |
Immunogenicity of the pentavalent rotavirus vaccine in African infants
|
Armah, George E.
|
|
2012
|
30 |
S1 |
p. A86-A93
nvt p.
|
article
|
| 15 |
Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines
|
Patel, Manish
|
|
2012
|
30 |
S1 |
p. A30-A35
nvt p.
|
article
|
| 16 |
Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh
|
Feller, Andrea J.
|
|
2012
|
30 |
S1 |
p. A101-A105
nvt p.
|
article
|
| 17 |
Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh
|
Zaman, K.
|
|
2012
|
30 |
S1 |
p. A94-A100
nvt p.
|
article
|
| 18 |
Molecular characterization of rotavirus strains detected during a clinical trial of a human rotavirus vaccine in Blantyre, Malawi
|
Nakagomi, Toyoko
|
|
2012
|
30 |
S1 |
p. A140-A151
nvt p.
|
article
|
| 19 |
Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011–2030
|
Atherly, Deborah E.
|
|
2012
|
30 |
S1 |
p. A7-A14
nvt p.
|
article
|
| 20 |
Research priorities regarding rotavirus vaccine and intussusception: A meeting summary
|
Tate, Jacqueline E.
|
|
2012
|
30 |
S1 |
p. A179-A184
nvt p.
|
article
|
| 21 |
Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: Benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines
|
Lloyd-Johnsen, C.
|
|
2012
|
30 |
S1 |
p. A190-A195
nvt p.
|
article
|
| 22 |
Rotavirus vaccines for children in developing countries: Understanding the science, maximizing the impact, and sustaining the effort
|
Neuzil, Kathleen M.
|
|
2012
|
30 |
S1 |
p. A1-A2
nvt p.
|
article
|
| 23 |
Rotavirus vaccines in developing countries: The potential impact, implementation challenges, and remaining questions
|
Cherian, Thomas
|
|
2012
|
30 |
S1 |
p. A3-A6
nvt p.
|
article
|
| 24 |
Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq®, in Kenya, including among HIV-infected and HIV-exposed infants
|
Laserson, Kayla F.
|
|
2012
|
30 |
S1 |
p. A61-A70
nvt p.
|
article
|
| 25 |
Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa
|
Tapia, Milagritos D.
|
|
2012
|
30 |
S1 |
p. A79-A85
nvt p.
|
article
|
| 26 |
Severity of rotavirus gastroenteritis in Indian children requiring hospitalization
|
Sowmyanarayanan, Thuppal V.
|
|
2012
|
30 |
S1 |
p. A167-A172
nvt p.
|
article
|
| 27 |
Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: Insights for understanding the impact of rotavirus vaccination programs
|
Bányai, Krisztián
|
|
2012
|
30 |
S1 |
p. A122-A130
nvt p.
|
article
|
| 28 |
Workshop on intussusception in African countries – Meeting report
|
Steele, A. Duncan
|
|
2012
|
30 |
S1 |
p. A185-A189
nvt p.
|
article
|
Journal description